Drug intelligence / Profile preview

cationorm

Development stage
Phase 4
Lead developer
Santen Pharmaceutical
Modality
Nanoparticles → Drug Delivery Systems
Administration
Ophthalmic
01

Overview

Cationorm is a preservative-free, cationic oil-in-water ophthalmic emulsion designed to alleviate the symptoms of dry eye syndrome (keratoconjunctivitis sicca). It utilizes the proprietary Novasorb technology, which creates positively charged nanodroplets that are electrostatically attracted to the negatively charged surface of the eye. This mechanism facilitates the even distribution of the emulsion across the ocular surface and prolongs its residence time. By replenishing the lipid layer of the tear film, Cationorm reduces tear evaporation and helps maintain ocular surface hydration, thereby addressing discomfort, burning, and itching associated with various forms of dry eye, including aqueous-deficient and evaporative dry eye.

Brand names
Cationorm
Other names
cationic ophthalmic emulsion

Beyond the preview

Go deeper on cationorm.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on cationorm.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call